These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38311473)

  • 21. Prenatal Lead Exposure Modifies the Impact of Maternal Self-Esteem on Children's Inattention Behavior.
    Xu J; Hu H; Wright R; Sánchez BN; Schnaas L; Bellinger DC; Park SK; Martínez S; Hernández-Avila M; Téllez-Rojo MM; Wright RO
    J Pediatr; 2015 Aug; 167(2):435-41. PubMed ID: 26047683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-esteem in special education children with ADHD: relationship to disorder characteristics and medication use.
    Bussing R; Zima BT; Perwien AR
    J Am Acad Child Adolesc Psychiatry; 2000 Oct; 39(10):1260-9. PubMed ID: 11026180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and validity of the Chinese version of the kiddie-schedule for affective disorders and schizophrenia-present and lifetime version DSM-5 (K-SADS-PL-C DSM-5).
    Dun Y; Li QR; Yu H; Bai Y; Song Z; Lei C; Li HH; Gong J; Mo Y; Li Y; Pei XY; Yuan J; Li N; Xu CY; Lai QY; Fu Z; Zhang KF; Song JY; Kang SM; Sun L; Wang YF; Yang L; Cao QJ
    J Affect Disord; 2022 Nov; 317():72-78. PubMed ID: 36029880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
    Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP
    Encephale; 2005; 31(3):337-48. PubMed ID: 16142049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial.
    Lam AP; Matthies S; Graf E; Colla M; Jacob C; Sobanski E; Alm B; Rösler M; Retz W; Retz-Junginger P; Kis B; Abdel-Hamid M; Müller HHO; Lücke C; Huss M; Jans T; Berger M; Tebartz van Elst L; Philipsen A;
    JAMA Netw Open; 2019 May; 2(5):e194980. PubMed ID: 31150084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
    Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal trajectories of ADHD symptomatology in offspring of parents with bipolar disorder and community controls.
    Kim JW; Yu H; Ryan ND; Axelson DA; Goldstein BI; Goldstein TR; Diler RS; Monk K; Hickey MB; Sakolsky DJ; Merranko JA; Birmaher B
    J Clin Psychiatry; 2015 May; 76(5):599-606. PubMed ID: 26035189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopathological features in Noonan syndrome.
    Perrino F; Licchelli S; Serra G; Piccini G; Caciolo C; Pasqualetti P; Cirillo F; Leoni C; Digilio MC; Zampino G; Tartaglia M; Alfieri P; Vicari S
    Eur J Paediatr Neurol; 2018 Jan; 22(1):170-177. PubMed ID: 29037749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.
    Soutullo C; Banaschewski T; Lecendreux M; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Bloomfield R; Squires LA; Coghill DR
    CNS Drugs; 2013 Sep; 27(9):743-51. PubMed ID: 23801529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).
    Kim YS; Cheon KA; Kim BN; Chang SA; Yoo HJ; Kim JW; Cho SC; Seo DH; Bae MO; So YK; Noh JS; Koh YJ; McBurnett K; Leventhal B
    Yonsei Med J; 2004 Feb; 45(1):81-9. PubMed ID: 15004873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidity of attention-deficit/hyperactivity disorder and bipolar disorder in North Indian clinic children and adolescents.
    Sivakumar T; Agarwal V; Sitholey P
    Asian J Psychiatr; 2013 Jun; 6(3):235-42. PubMed ID: 23642982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Kosheleff AR; Hull JT; Liranso T; Qin P; Busse GD; O'Neal W; Fava M; Faraone SV; Rubin J
    J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):214-226. PubMed ID: 33600233
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship between chronotype and obesity in children and adolescent with attention deficit hyperactivity disorder.
    Türkoğlu S; Çetin FH
    Chronobiol Int; 2019 Aug; 36(8):1138-1147. PubMed ID: 31177853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Psychometric Properties and Factorial Structure of ADHD Module of K-SADS-PL in Children From Rural Kenya.
    Kariuki SM; Newton CRJC; Abubakar A; Bitta MA; Odhiambo R; Phillips Owen J
    J Atten Disord; 2020 Dec; 24(14):2064-2071. PubMed ID: 29392964
    [No Abstract]   [Full Text] [Related]  

  • 36. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
    Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: clinical features and familial transmission.
    Antshel KM; Kaul P; Biederman J; Spencer TJ; Hier BO; Hendricks K; Faraone SV
    J Clin Psychiatry; 2013 Mar; 74(3):e197-204. PubMed ID: 23561240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder.
    Diler RS; Uguz S; Seydaoglu G; Erol N; Avci A
    Bipolar Disord; 2007 May; 9(3):243-51. PubMed ID: 17430299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with problematic internet use among children and adolescents with Attention Deficit Hyperactivity Disorder.
    Cakmak FH; Gul H
    North Clin Istanb; 2018; 5(4):302-313. PubMed ID: 30859160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Effects of ADHD Subtypes in Patients With Social Anxiety Disorder.
    Koyuncu A; Çelebi F; Ertekin E; Kök BE; Tükel R
    J Atten Disord; 2019 Oct; 23(12):1464-1469. PubMed ID: 26637843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.